165 related articles for article (PubMed ID: 25666297)
41. [Neuroendocrine pulmonary neoplasms: improved diagnosis by DOTATOC- vs. FDG-PET/CT].
Frechen D; Temur Y; Cornelissen C; Kweider S; Krüger S
Pneumologie; 2011 Oct; 65(10):628-30. PubMed ID: 22015488
[No Abstract] [Full Text] [Related]
42. 18F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography in symmetrically enlarged axillary and inguinal lymph nodes of Ofuji's papuloerythroderma.
Lee SH; Kim JS; Lee JH; Zheng Z; Cho SB
Leuk Lymphoma; 2012 Mar; 53(3):511-3. PubMed ID: 21867461
[No Abstract] [Full Text] [Related]
43. [The use of PET/CT in radiotherapy of patients with non-small cell lung cancer].
Lõcsei Z; Hideghéty K; Farkas R; Bellyei S; Sárosi V; Sebestyén K; Sebestyén Z; Kovács P; Mangel L
Magy Onkol; 2011 Nov; 55(4):274-80. PubMed ID: 22128310
[TBL] [Abstract][Full Text] [Related]
44. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Choi JY; Kwon OJ; Shim YM; Kim S
Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441
[TBL] [Abstract][Full Text] [Related]
45. Giant thoracic ganglioneuroma in a pediatric patient: staging and restaging with ¹⁸F-FDG PET-CT.
Agarwal KK; Sharma P; Kc SS; Bal C; Kumar R
Rev Esp Med Nucl Imagen Mol; 2014; 33(5):310-1. PubMed ID: 25017382
[No Abstract] [Full Text] [Related]
46. Gastrointestinal stromal tumour with unusual sites of metastasis: accurate staging with ¹⁸F-FDG PET/CT.
Mukherjee A; Karunanithi S; Singla S; Bal C; Kumar R
Rev Esp Med Nucl Imagen Mol; 2015; 34(1):60-1. PubMed ID: 25263720
[No Abstract] [Full Text] [Related]
47. [Thyroid metastases of pulmonary origin diagnosed by (18)F-FDG PET-CT].
Moragas M; Moreno C; Mourelo S; Soler M; Riera E; García JR
Rev Esp Med Nucl Imagen Mol; 2014; 33(4):243-4. PubMed ID: 24656755
[No Abstract] [Full Text] [Related]
48. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
Nakagawa M; Hara M; Sakurai K; Ozawa Y; Mizuno A; Tamaki T; Nishio M; Shibamoto Y
Acta Radiol; 2009 Jul; 50(6):638-44. PubMed ID: 19492198
[TBL] [Abstract][Full Text] [Related]
49. Role of positron emission tomography-computed tomography in pulmonary neoplasms.
Shreve P; Faasse T
Radiol Clin North Am; 2013 Sep; 51(5):767-79. PubMed ID: 24010905
[TBL] [Abstract][Full Text] [Related]
50. Diagnostic and staging impact of radiotherapy planning FDG-PET-CT in non-small-cell lung cancer.
Lin P; Koh ES; Lin M; Vinod SK; Ho-Shon I; Yap J; Som S
Radiother Oncol; 2011 Nov; 101(2):284-90. PubMed ID: 21777988
[TBL] [Abstract][Full Text] [Related]
51. Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer.
Everitt S; Hicks RJ; Ball D; Kron T; Schneider-Kolsky M; Walter T; Binns D; Mac Manus M
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1098-104. PubMed ID: 19386444
[TBL] [Abstract][Full Text] [Related]
52. ¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer.
Groheux D; Hindié E; Marty M; Espié M; Rubello D; Vercellino L; Bousquet G; Ohnona J; Toubert ME; Merlet P; Misset JL
Eur J Radiol; 2014 Oct; 83(10):1925-33. PubMed ID: 24985086
[TBL] [Abstract][Full Text] [Related]
53. Lung cancer.
Akhurst T; MacManus M; Hicks RJ
PET Clin; 2015 Apr; 10(2):147-58. PubMed ID: 25829084
[TBL] [Abstract][Full Text] [Related]
54. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
Darling GE; Maziak DE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Gu CS; Kuruvilla MS; Cline KJ; Julian JA; Evans WK; Levine MN
J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082
[TBL] [Abstract][Full Text] [Related]
55. Asymmetric muscle activity on (18)F-FDG PET/CT.
Palard X; Carai S; Le Roux PY; Salaün PY; Abgral R
Clin Nucl Med; 2015 Jun; 40(6):e336-7. PubMed ID: 25706792
[TBL] [Abstract][Full Text] [Related]
56. [Diagnostic value of (18)F-FDG PET/CT imaging plus serum tumor marker assays for pulmonary lesions and clinical significance of SUVmax].
Zhang TM; Zhang LM; Liu Y; Zhang ZF; Wang CL
Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(41):2901-4. PubMed ID: 23328236
[TBL] [Abstract][Full Text] [Related]
57. Findings in the Gerstmann-Sträussler-Scheinker syndrome in an 18F-FDG PET-CT study.
Achury C; Camacho V; Fernández A; Gómez-Ansón B; Jaller R; Carrió I
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):352-3. PubMed ID: 23084018
[No Abstract] [Full Text] [Related]
58. Comparative Performance of ¹⁸F-FDG PET/MRI and ¹⁸F-FDG PET/CT in Detection and Characterization of Pulmonary Lesions in 121 Oncologic Patients.
Sawicki LM; Grueneisen J; Buchbender C; Schaarschmidt BM; Gomez B; Ruhlmann V; Wetter A; Umutlu L; Antoch G; Heusch P
J Nucl Med; 2016 Apr; 57(4):582-6. PubMed ID: 26742715
[TBL] [Abstract][Full Text] [Related]
59. Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer.
Briggs RH; Chowdhury FU; Lodge JP; Scarsbrook AF
Clin Radiol; 2011 Dec; 66(12):1167-74. PubMed ID: 21867996
[TBL] [Abstract][Full Text] [Related]
60. [Lipomatous hypertrophy of the interatrial septum: findings in the (18)F-FDG PET/CT scan].
García JR; Vollmer I; Soler M; Alvarez-Moro FJ; Fuertes S; Huguet M; Moragas M; Lomeña F
Rev Esp Med Nucl; 2011; 30(6):382-3. PubMed ID: 21549451
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
